Abstract | BACKGROUND: Adhesion molecules are thought to play a key role in inflammatory processes in bronchial asthma. We previously observed an increased expression of the beta2-integrin family on an eosinophilic cell line (EoL-1) by platelet-activating factor (PAF). OBJECTIVE: MATERIAL AND METHODS: EoL-1 cells (1x10(6)/mL) were incubated in the presence or absence of 10(-6) M ibudilast (KC-404), then cells were cultured in the presence or absence of PAF (10(-7) M) for 45 minutes. Flow cytometric analysis for CD11a, CD11b, and CD18 expression was examined. RESULTS:
Ibudilast had an inhibitory effect on beta2 integrin expression induced by PAF [CD11a: 84.8% versus 73.1% (preincubation with ibudilast), CD11b: 35.8% versus 26.2%, CD18 74.9% versus 65.6%]. CONCLUSIONS:
Ibudilast (KC-404) has anti-inflammatory activities through its inhibitory effect on the expression of adhesion molecules on eosinophils.
|
Authors | J Chihara, O Urayama, H Kayaba, K Honda, N Saito, N Hayashi, D Kurachi, T Yamamoto |
Journal | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
(Ann Allergy Asthma Immunol)
Vol. 81
Issue 5
Pg. 448-50
(Nov 1998)
ISSN: 1081-1206 [Print] United States |
PMID | 9860039
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bronchodilator Agents
- CD18 Antigens
- Integrins
- Lymphocyte Function-Associated Antigen-1
- Macrophage-1 Antigen
- Platelet Activating Factor
- Platelet Aggregation Inhibitors
- Pyridines
- ibudilast
|
Topics |
- Asthma
(drug therapy)
- Bronchodilator Agents
(pharmacology)
- CD18 Antigens
(biosynthesis)
- Humans
- Integrins
(biosynthesis, drug effects)
- Lymphocyte Function-Associated Antigen-1
(biosynthesis)
- Macrophage-1 Antigen
(biosynthesis)
- Platelet Activating Factor
(pharmacology)
- Platelet Aggregation Inhibitors
(pharmacology)
- Pyridines
(pharmacology)
- Tumor Cells, Cultured
(metabolism)
|